From PBS News Hour:
Rebecca Riggins, an assistant professor of oncology at Georgetown University, was about to stick a FedEx shipping label onto a package containing about two dozen samples of human breast tumors for analysis when the phone rang. Her team was in the process of investigating why certain types of breast cancer respond well to the common hormone therapy Tamoxifen while others fare poorly. The tumor analysis was a critical part of the project.
The Feb. 25 phone call was from her colleague, the study's principal investigator. Program officials at the National Institutes of Health had just told him to expect at least a 50 percent reduction in funding to their research. It was part of the sequestration cuts to the federal budget, which include 5.1 percent cuts across the board to non-defense agencies.
She had no choice but to put the mailing on hold and move the samples to the freezer, where they remain today.
Riggins' team can no longer afford to continue some of their more expensive experiments, like the tumor analyses. And they're scaling back their smaller experiments involving breast cancer cells grown in the lab and mouse model studies.I swear I do not hope Senator Portman's son gets breast cancer. But it would be nice if something got their attention.
No comments:
Post a Comment